33 VCs and 3 funds investing in Consumer Health
CEO & Partner
AirTree Ventures (Web3)
Check: Neither Airtree nor Elicia publishes her personal check range or decision authority. Airtree describes itself as seed-first and able to support companies through their journey; a historic Fund III article mentioned a $200k seed entry point, but that is firm- and vintage-specific rather than a current personal range.
Elicia backs highly ambitious, resilient founders from Australia and New Zealand, often beginning at pre-seed or seed and supporting them across later rounds. Her disclosed portfolio spans AI-enabled enterprise software, workforce intelligence, healthcare, agricultural and climate technology, and B2B SaaS. Her writing emphasizes technology's capacity for positive impact, founder ambition, durable relationships, product love, domain depth, and accepting concentrated venture risk in pursuit of outlier outcomes.
Investor
BoxGroup
Check: No reliable Arielle-specific check size is public. BoxGroup describes itself as an earliest-stage investor, but founders should confirm current round fit and allocation directly rather than relying on third-party range estimates.
Arielle invests within BoxGroup's broad earliest-stage mandate. Her differentiated documented context is technical and translational: Harvard bioengineering research, founding a postpartum medical-device project, product work in fertility AI and neuromodulation, mechanical engineering at a bioelectronic-medicine startup, and consulting at BCG. This supports a credible ability to evaluate user need, clinical workflow, product design, manufacturing, regulatory planning and commercialization in technical health businesses. It does not establish an exclusive healthcare mandate or a personally published investment thesis.
Venture Partner
GreyMatter
Check: GreyMatter does not publish a standard current check-size range on its official site.
Natalie Bartlett invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.
Director of Investor Relations
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Sathya Shanthakumar is listed in a Director of Investor Relations capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Founder & Managing Partner
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Lynne Chou O'Keefe invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.
Venture Partner
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Bruce Broussard invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.
Venture Partner
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Frank Williams invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.
Venture Partner
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Carolyn Magill invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.
Head of People
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Karsten Vagner is listed in a Head of People capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.
VP of Finance & Operations
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Shannon Knous is listed in a VP of Finance & Operations capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.
Head of Marketing
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Lauren O'Mahony is listed in a Head of Marketing capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.
Administrative Assistant & Office Manager
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Katharine Morris is listed in a Administrative Assistant & Office Manager capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.
Founding Partner
GreyMatter
Check: GreyMatter does not publish a standard current check-size range on its official site.
Danish Munir invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.
Principal
GreyMatter
Check: GreyMatter does not publish a standard current check-size range on its official site.
Anna Wang invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.
Founding Partner
GreyMatter
Check: GreyMatter does not publish a standard current check-size range on its official site.
Andrew Barr invests or supports investments through GreyMatter's published strategy: Back early founders transforming mental health through better access, outcomes, infrastructure, science and experiences.
Investor
BoxGroup
Check: BoxGroup publicly invests up to $1M. Third-party profiles estimate Disha's range at $500K–$1M, but no primary source confirms a personal range, so the firm ceiling is the safer planning assumption.
Disha invests at the earliest stages with a differentiated mix of finance, neuroscience, biotech R&D, and prior growth-investing exposure. Her public investor profile points to AI, enterprise infrastructure and software, digital and consumer health, biotech, and commerce. Within BoxGroup's generalist model, the through-line is an exceptional founder using technical or domain insight to create a category, not a rigid sector checklist.
Operating Partner
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
David Schonthal is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Operating Partner
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Tom Richards is listed in a Operating Partner capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Senior Associate
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Cameron Raglin invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.
Director of Finance
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Joslin Owens is listed in a Director of Finance capacity at 7wire Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Partner
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Glen Tullman invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.
Partner
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Lee Shapiro invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.
Partner
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Robert Garber invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.
Partner
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Alyssa Jaffee invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.
Principal
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Chuka Esiobu invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.
Principal
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Garrett Howard invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.
Partner
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Michael Wert invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.
Principal
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Hong Truong invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.
Principal
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Anish Aitharaju invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.
Accounting & Operations Manager
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Erin Hardy is listed in a Accounting & Operations Manager capacity at Define Ventures. This profile preserves that functional distinction; the firm's investment mandate is included only as shared context.
Partner
Define Ventures
Check: Define Ventures does not publish a standard current check-size range; it reports six funds and $800M under management.
Chirag Shah invests or supports investments through Define Ventures's published strategy: Back category-defining healthcare companies that combine deep ecosystem understanding with a technology-driven mindset across enterprise, value-based care and consumer health.
Principal
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Tiffany Yu invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.
Associate
7wire Ventures
Check: 7wire Ventures does not publish a standard current check-size range on its official site.
Eric Shan invests or supports investments through 7wire Ventures's published strategy: Build and back early-stage digital-health companies that give informed, connected consumers more control and improve healthcare quality, access, outcomes and cost.